Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Cannabinoid receptor 2 | ||
| Ligand | BDBM50448271 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_975836 (CHEMBL2415441) | ||
| EC50 | 15±n/a nM | ||
| Citation |  Tourteau, A; Andrzejak, V; Body-Malapel, M; Lemaire, L; Lemoine, A; Mansouri, R; Djouina, M; Renault, N; El Bakali, J; Desreumaux, P; Muccioli, GG; Lambert, DM; Chavatte, P; Rigo, B; Leleu-Chavain, N; Millet, R 3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis. Bioorg Med Chem21:5383-94 (2013) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Cannabinoid receptor 2 | |||
| Name: | Cannabinoid receptor 2 | ||
| Synonyms: | CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2 | ||
| Type: | G Protein-Coupled Receptor (GPCR) | ||
| Mol. Mass.: | 39690.94 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P34972 | ||
| Residue: | 360 | ||
| Sequence: |
| ||
| BDBM50448271 | |||
| n/a | |||
| Name | BDBM50448271 | ||
| Synonyms: | CHEMBL2414028 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C25H32N2O3 | ||
| Mol. Mass. | 408.5332 | ||
| SMILES | CCCCCOc1ccccc1-c1cc(no1)C(=O)NC1C2CC3CC(C2)CC1C3 |TLB:19:20:22:26.24.25,THB:24:23:20:26.25.27,24:25:22.23.29:20,27:25:22:29.28.20,27:28:22:26.24.25,(14.78,-14.02,;15.56,-12.7,;14.81,-11.36,;15.59,-10.04,;14.84,-8.7,;15.62,-7.38,;14.86,-6.04,;13.32,-6.03,;12.57,-4.67,;13.35,-3.35,;14.9,-3.37,;15.64,-4.72,;17.19,-4.74,;17.68,-3.28,;19.27,-3.33,;19.69,-4.77,;18.44,-5.67,;20.03,-1.98,;19.25,-.65,;21.58,-1.97,;22.84,-2.86,;22.85,-4.35,;21.65,-5.62,;23.15,-5.21,;24.57,-5.78,;25.57,-4.49,;24.17,-4.84,;25.59,-2.96,;24.18,-2.38,;23.14,-3.62,)| | ||
| Structure | 
| ||